Literature DB >> 25779994

Added value of screening for CKD among the elderly or persons with low socioeconomic status.

Priya Vart1, Sjimen A Reijneveld2, Ute Bültmann2, Ronald T Gansevoort3.   

Abstract

BACKGROUND AND
OBJECTIVE: Three screening approaches were compared for their ability to detect CKD cases, and identify patients with CKD who have a higher rate of incident cardiovascular disease (CVD) events and renal function decline. Approach 1 was the traditional CKD screening approach, targeting only individuals with known diabetes, hypertension, or CVD history. Approach 2 was defined as Approach 1+elderly, and Approach 3 as Approach 1+low-socioeconomic status (SES) individuals. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data on 3411 individuals from the general population in The Netherlands were examined. Individuals aged >60 years were classified as elderly. Persons with low SES was defined as those with primary school or below primary school education. CKD was diagnosed during outpatient clinic visits. Individuals were followed for 9.4±2.6 years during four screening rounds.
RESULTS: At baseline, 16%, 29%, and 25% of the general population was to be screened and 36%, 59%, and 51% of the CKD (n=263) cases were detected in Approaches 1, 2, and 3, respectively. The numbers of individuals needed to screen to detect one CKD case were 5.6 in Approach 1 and 6.5 each in Approach 2 and 3. In Approach 2 the hazard ratio for incident CVD events was 1.87 (95% confidence interval [95% CI], 1.35 to 2.61) in detected and 1.92 (95% CI, 1.01 to 3.64) in undetected CKD cases compared with persons without CKD, whereas in Approach 3 these values were 2.31 (95% CI, 1.64 to 3.25) and 1.28 (95% CI, 0.77 to 2.13), respectively. In Approach 2, the rate of renal function decline was -1.37 ml/min per 1.73 m(2) per year in detected and -1.13 ml/min per 1.73 m(2) per year in undetected CKD cases. In Approach 3, these figures were -1.41 and -1.14 ml/min per 1.73 m(2) per year, respectively.
CONCLUSIONS: Adding persons with low SES, rather than adding elderly persons, to the traditional high-risk groups may help detect more persons with CKD who have a higher rate of future CVD events and renal function decline.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; cardiovascular disease; epidemiology and outcomes; renal progression

Mesh:

Year:  2015        PMID: 25779994      PMCID: PMC4386261          DOI: 10.2215/CJN.09030914

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

1.  Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

3.  Socioeconomic status in health research: one size does not fit all.

Authors:  Paula A Braveman; Catherine Cubbin; Susan Egerter; Sekai Chideya; Kristen S Marchi; Marilyn Metzler; Samuel Posner
Journal:  JAMA       Date:  2005-12-14       Impact factor: 56.272

Review 4.  Measuring social class in US public health research: concepts, methodologies, and guidelines.

Authors:  N Krieger; D R Williams; N E Moss
Journal:  Annu Rev Public Health       Date:  1997       Impact factor: 21.981

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Progression of kidney dysfunction in the community-dwelling elderly.

Authors:  B R Hemmelgarn; J Zhang; B J Manns; M Tonelli; E Larsen; W A Ghali; D A Southern; K McLaughlin; G Mortis; B F Culleton
Journal:  Kidney Int       Date:  2006-03-08       Impact factor: 10.612

7.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

8.  Chronic kidney disease: the distribution of health care dollars.

Authors:  Wendy L St Peter; Samina S Khan; James P Ebben; Brian J G Pereira; Allan J Collins
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

9.  Socioeconomic measures and CKD in the United States and The Netherlands.

Authors:  Priya Vart; Ron T Gansevoort; Josef Coresh; Sijmen A Reijneveld; Ute Bültmann
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  10 in total

1.  Socioeconomic Position and Incidence of Glomerular Diseases.

Authors:  Mark Canney; Dilshani Induruwage; Anahat Sahota; Cathal McCrory; Michelle A Hladunewich; Jagbir Gill; Sean J Barbour
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-20       Impact factor: 8.237

2.  To screen or not to screen: that is not (yet) the question.

Authors:  Delphine S Tuot; Carmen A Peralta
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-16       Impact factor: 8.237

Review 3.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

4.  Acute Kidney Injury, Age, and Socioeconomic Deprivation: Evaluation of a National Data Set.

Authors:  Jennifer Holmes; Dafydd Phillips; Kieron Donovan; John Geen; John D Williams; Aled O Phillips
Journal:  Kidney Int Rep       Date:  2019-03-21

5.  Duality of Tocopherol Isoforms and Novel Associations with Vitamins Involved in One-Carbon Metabolism: Results from an Elderly Sample of the LifeLines Cohort Study.

Authors:  Camilo G Sotomayor; Isidor Minović; Manfred L Eggersdorfer; Ineke J Riphagen; Martin H de Borst; Louise H Dekker; Ilja M Nolte; Jan Frank; Sander K R van Zon; Sijmen A Reijneveld; Jan C van der Molen; Michel J Vos; Jenny E Kootstra-Ros; Ramón Rodrigo; Ido P Kema; Gerjan J Navis; Stephan J L Bakker
Journal:  Nutrients       Date:  2020-02-23       Impact factor: 5.717

6.  The Impact of Pharmacist-delivered Motivational Interviewing on Chronic Kidney Disease Identification and Management in Patients with Diabetes Mellitus and Low Socioeconomic Status.

Authors:  Keri DePatis; Catherine Harrington
Journal:  Innov Pharm       Date:  2019-10-31

7.  Risk Factors Associated With Abnormal Urinalysis in Children.

Authors:  Xuhui Zhong; Jie Ding; Zheng Wang; Yan Gao; Yubin Wu; Ying Shen; Hongmei Song; Zhengyan Zhao; Xinxin Chen; Puhong Zhang; Guobin Xu; Chen Yao; Hui Zhang; Fu Zhong; Ying Tang; Hui Wang; Wei Wang; Wenhao Li; Wanxia Zhang; Sainan Zhu; Meixia Shang
Journal:  Front Pediatr       Date:  2021-03-25       Impact factor: 3.418

8.  Discrepancies in estimated glomerular filtration rate and albuminuria levels in ethnic minority groups - The multiethnic HELIUS cohort study.

Authors:  Brechje J M V Huisman; Charles Agyemang; Bert-Jan H van den Born; Ron J G Peters; Marieke B Snijder; Liffert Vogt
Journal:  EClinicalMedicine       Date:  2022-03-05

9.  External validation of six clinical models for prediction of chronic kidney disease in a German population.

Authors:  Susanne Stolpe; Bernd Kowall; Denise Zwanziger; Mirjam Frank; Karl-Heinz Jöckel; Raimund Erbel; Andreas Stang
Journal:  BMC Nephrol       Date:  2022-08-01       Impact factor: 2.585

10.  The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey.

Authors:  Florica Gadalean; Daniel Lighezan; Dana Stoian; Oana Schiller; Romulus Timar; Bogdan Timar; Flaviu Bob; Mihaela Dora Donciu; Mircea Munteanu; Adelina Mihaescu; Adrian Covic; Adalbert Schiller
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.